Can We Predict Daily Adherence to Warfarin?: Results From the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study

Warfarin is the primary therapy to prevent stroke and venous thromboembolism. Significant periods of nonadherence frequently go unreported by patients and undetected by providers. Currently, no comprehensive screening tool exists to help providers assess the risk of nonadherence at the time of initi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chest 2010-04, Vol.137 (4), p.883-889
Hauptverfasser:	PLATT, Alec B, LOCALIO, A. Russell, NEWCOMB, Craig W, STROM, Brian L, LASKIN, Mitchell S, KIMMEL, Stephen E, BRENSINGER, Colleen M, CRUESS, Dean G, CHRISTIE, Jason D, GROSS, Robert, PARKER, Catherine S, PRICE, Maureen, METLAY, Joshua P, COHEN, Abigail
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anticoagulants - therapeutic use Biological and medical sciences Cardiology. Vascular system Cohort Studies Female Humans Logistic Models Longitudinal Studies Male Medical sciences Medication Adherence - psychology Middle Aged Models, Statistical Original Research Outcome Assessment (Health Care) Patient Compliance - psychology Pneumology Prospective Studies Psychology Socioeconomic Factors Stroke - prevention & control Thromboembolism - prevention & control Warfarin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!